These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

204 related articles for article (PubMed ID: 35468860)

  • 1. Structural and community changes during COVID-19 and their effects on overdose precursors among rural people who use drugs: a mixed-methods analysis.
    Walters SM; Bolinski RS; Almirol E; Grundy S; Fletcher S; Schneider J; Friedman SR; Ouellet LJ; Ompad DC; Jenkins W; Pho MT
    Addict Sci Clin Pract; 2022 Apr; 17(1):24. PubMed ID: 35468860
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Multi-level influences on increased overdose risk behaviors during the COVID-19 pandemic among people who use drugs in Rhode Island: a qualitative investigation.
    Frueh L; Collins AB; Newman R; Barnett NP; Rich JD; Clark MA; Marshall BDL; Macmadu A
    Harm Reduct J; 2023 Feb; 20(1):14. PubMed ID: 36739417
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The Impact of the COVID-19 Pandemic on Drug Use Behaviors, Fentanyl Exposure, and Harm Reduction Service Support among People Who Use Drugs in Rural Settings.
    Bolinski RS; Walters S; Salisbury-Afshar E; Ouellet LJ; Jenkins WD; Almirol E; Van Ham B; Fletcher S; Johnson C; Schneider JA; Ompad D; Pho MT
    Int J Environ Res Public Health; 2022 Feb; 19(4):. PubMed ID: 35206421
    [TBL] [Abstract][Full Text] [Related]  

  • 4. "It's just a perfect storm": Exploring the consequences of the COVID-19 pandemic on overdose risk in British Columbia from the perspectives of people who use substances.
    Foreman-Mackey A; Xavier J; Corser J; Fleury M; Lock K; Mehta A; Lamb J; McDougall J; Newman C; Buxton JA
    BMC Public Health; 2023 Apr; 23(1):640. PubMed ID: 37013524
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The Impacts of COVID-19 on Mental Health, Substance Use, and Overdose Concerns of People Who Use Drugs in Rural Communities.
    Stack E; Leichtling G; Larsen JE; Gray M; Pope J; Leahy JM; Gelberg L; Seaman A; Korthuis PT
    J Addict Med; 2021 Sep-Oct 01; 15(5):383-389. PubMed ID: 33156181
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Impact of COVID-19 among people who use drugs: A qualitative study with harm reduction workers and people who use drugs.
    Conway FN; Samora J; Brinkley K; Jeong H; Clinton N; Claborn KR
    Harm Reduct J; 2022 Jul; 19(1):72. PubMed ID: 35780109
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Volatile drug use and overdose during the first year of the COVID-19 pandemic in the United States.
    Schneider KE; Martin EM; Allen ST; Morris M; Haney K; Saloner B; Sherman SG
    Int J Drug Policy; 2024 Apr; 126():104371. PubMed ID: 38447262
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A qualitative study on overdose response in the era of COVID-19 and beyond: how to spot someone so they never have to use alone.
    Perri M; Kaminski N; Bonn M; Kolla G; Guta A; Bayoumi AM; Challacombe L; Gagnon M; Touesnard N; McDougall P; Strike C
    Harm Reduct J; 2021 Aug; 18(1):85. PubMed ID: 34353323
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A rapid ethnographic study of risk negotiation during the COVID-19 pandemic among unstably housed people who use drugs in Rhode Island.
    Collins AB; Edwards S; McNeil R; Goldman J; Hallowell BD; Scagos RP; Marshall BDL
    Int J Drug Policy; 2022 May; 103():103626. PubMed ID: 35228056
    [TBL] [Abstract][Full Text] [Related]  

  • 10. People, places, and stigma: A qualitative study exploring the overdose risk environment in rural Kentucky.
    Fadanelli M; Cloud DH; Ibragimov U; Ballard AM; Prood N; Young AM; Cooper HLF
    Int J Drug Policy; 2020 Nov; 85():102588. PubMed ID: 31753603
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A Qualitative Exploration of the Functional, Social, and Emotional Impacts of the COVID-19 Pandemic on People Who Use Drugs.
    Kelly EL; Reed MK; Schoenauer KM; Smith K; Scalia-Jackson K; Kay Hill S; Li E; Weinstein L
    Int J Environ Res Public Health; 2022 Aug; 19(15):. PubMed ID: 35955107
    [TBL] [Abstract][Full Text] [Related]  

  • 12. An exploratory study of a hands-on naloxone training for rural clinicians and staff.
    Cody SL; Hines CB; Glenn CJ; Sharp-Marbury R; Newman S
    J Nurs Scholarsh; 2023 May; 55(3):599-604. PubMed ID: 36411494
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Responding to a surge in overdose deaths: perspectives from US syringe services programs.
    Frost MC; Austin EJ; Corcorran MA; Briggs ES; Behrends CN; Juarez AM; Frank ND; Healy E; Prohaska SM; LaKosky PA; Kapadia SN; Perlman DC; Schackman BR; Des Jarlais DC; Williams EC; Glick SN
    Harm Reduct J; 2022 Jul; 19(1):79. PubMed ID: 35854351
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evaluation of risk mitigation measures for people with substance use disorders to address the dual public health crises of COVID-19 and overdose in British Columbia: a mixed-method study protocol.
    Nosyk B; Slaunwhite A; Urbanoski K; Hongdilokkul N; Palis H; Lock K; Min JE; Zhao B; Card KG; Barker B; Meilleur L; Burmeister C; Thomson E; Beck-McGreevy P; Pauly B
    BMJ Open; 2021 Jun; 11(6):e048353. PubMed ID: 34108170
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Exploring trauma and wellbeing of people who use drugs after witnessing overdose: A qualitative study.
    Song M; Desai IK; Meyer A; Shah H; Saloner B; Sherman SG; Allen ST; Tomko C; Schneider KE; Krawczyk N; Whaley S; Churchill J; Harris SJ
    Int J Drug Policy; 2023 Dec; 122():104239. PubMed ID: 37890394
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The impact of the novel coronavirus disease (COVID-19) pandemic on drug overdose-related deaths in the United States and Canada: a systematic review of observational studies and analysis of public health surveillance data.
    Imtiaz S; Nafeh F; Russell C; Ali F; Elton-Marshall T; Rehm J
    Subst Abuse Treat Prev Policy; 2021 Nov; 16(1):87. PubMed ID: 34844624
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Co-use of methamphetamine and opioids among people in treatment in Oregon: A qualitative examination of interrelated structural, community, and individual-level factors.
    Lopez AM; Dhatt Z; Howe M; Al-Nassir M; Billing A; Artigiani E; Wish ED
    Int J Drug Policy; 2021 May; 91():103098. PubMed ID: 33476863
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Studying how state health services delivery policies can mitigate the effects of disasters on drug addiction treatment and overdose: Protocol for a mixed-methods study.
    Eisenberg MD; McCourt A; Stuart EA; Rutkow L; Tormohlen KN; Fingerhood MI; Quintero L; White SA; McGinty EE
    PLoS One; 2021; 16(12):e0261115. PubMed ID: 34914779
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of COVID-19 on Overdose Risk Behaviors Among People Who Inject Drugs in Wisconsin.
    Bailey EJ; Westergaard RP; Kaya C; Becker M; Mijal K; Seal D; Gicquelais RE
    WMJ; 2023 Dec; 122(5):464-468. PubMed ID: 38180946
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A stakeholder-driven framework for measuring potential change in the health risks of people who inject drugs (PWID) during the COVID-19 pandemic.
    Bradley H; Austin C; Allen ST; Asher A; Bartholomew TS; Board A; Borquez A; Buchacz K; Carter A; Cooper HLF; Feinberg J; Furukawa N; Genberg B; Gorbach PM; Hagan H; Huriaux E; Hurley H; Luisi N; Martin NK; Rosenberg ES; Strathdee SA; Jarlais DCD
    Int J Drug Policy; 2022 Dec; 110():103889. PubMed ID: 36343431
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.